未接受Fontan姑息治疗的单心室患者的长期预后

IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Wayne C. Zheng , Yves d’Udekem , Leeanne E. Grigg , Dominica Zentner , Rachael Cordina , David S. Celermajer , Edward Buratto , Igor E. Konstantinov , Melissa G.Y. Lee
{"title":"未接受Fontan姑息治疗的单心室患者的长期预后","authors":"Wayne C. Zheng ,&nbsp;Yves d’Udekem ,&nbsp;Leeanne E. Grigg ,&nbsp;Dominica Zentner ,&nbsp;Rachael Cordina ,&nbsp;David S. Celermajer ,&nbsp;Edward Buratto ,&nbsp;Igor E. Konstantinov ,&nbsp;Melissa G.Y. Lee","doi":"10.1016/j.ijcchd.2023.100457","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Patients with single ventricle (SV) without Fontan palliation are uncommon, and their long-term outcomes remain unclear.</p></div><div><h3>Methods</h3><p>Retrospective study of 35 adult patients with SV without Fontan from two tertiary centers. Primary outcome was mortality.</p></div><div><h3>Results</h3><p>Median age at first follow-up was 31 years (IQR: 20–40). Most common defect was double inlet left ventricle (34%), and 69% had left ventricular morphology. Patients were unoperated (46%), had systemic-to-pulmonary artery shunt (31%) or bidirectional cavopulmonary shunt (23%) as final palliation. Most common reasons for not progressing to Fontan palliation were pulmonary vascular disease (54%), patient refusal (17%), Fontan takedown (14%), and hypoplastic pulmonary arteries (11%). Baseline mean hemoglobin was 195 ± 29 g/L, mean O<sub>2</sub> saturation 83 ± 6.9%, and 4 patients in NYHA Class III‒IV. After a mean follow-up of 10 ± 8.3 years, there were 9 deaths with heart failure being the leading cause (n = 6). Age-adjusted survival of these adult SV survivors was 73% and 53% at 40 and 50 years of age, respectively. Deceased patients more frequently had renal impairment (50% vs 0%) and QRS prolongation (75% vs 16%) at baseline (all p &lt; 0.05). During follow-up, 40% had a new arrhythmia (atrial: n = 14, ventricular: n = 3), 34% had one or more hospitalizations for heart failure, and 17% had a stroke. A greater proportion of patients with pre-existing or new atrial/ventricular arrhythmia died compared to those without (42% vs 6%, p = 0.02).</p></div><div><h3>Conclusions</h3><p>Patients with SV without Fontan have high mortality and a substantial burden of cardiovascular complications, particularly arrhythmia. QRS prolongation and renal impairment were associated with mortality.</p></div>","PeriodicalId":73429,"journal":{"name":"International journal of cardiology. Congenital heart disease","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term outcomes of patients with single ventricle who do not undergo Fontan palliation\",\"authors\":\"Wayne C. Zheng ,&nbsp;Yves d’Udekem ,&nbsp;Leeanne E. Grigg ,&nbsp;Dominica Zentner ,&nbsp;Rachael Cordina ,&nbsp;David S. Celermajer ,&nbsp;Edward Buratto ,&nbsp;Igor E. Konstantinov ,&nbsp;Melissa G.Y. Lee\",\"doi\":\"10.1016/j.ijcchd.2023.100457\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Patients with single ventricle (SV) without Fontan palliation are uncommon, and their long-term outcomes remain unclear.</p></div><div><h3>Methods</h3><p>Retrospective study of 35 adult patients with SV without Fontan from two tertiary centers. Primary outcome was mortality.</p></div><div><h3>Results</h3><p>Median age at first follow-up was 31 years (IQR: 20–40). Most common defect was double inlet left ventricle (34%), and 69% had left ventricular morphology. Patients were unoperated (46%), had systemic-to-pulmonary artery shunt (31%) or bidirectional cavopulmonary shunt (23%) as final palliation. Most common reasons for not progressing to Fontan palliation were pulmonary vascular disease (54%), patient refusal (17%), Fontan takedown (14%), and hypoplastic pulmonary arteries (11%). Baseline mean hemoglobin was 195 ± 29 g/L, mean O<sub>2</sub> saturation 83 ± 6.9%, and 4 patients in NYHA Class III‒IV. After a mean follow-up of 10 ± 8.3 years, there were 9 deaths with heart failure being the leading cause (n = 6). Age-adjusted survival of these adult SV survivors was 73% and 53% at 40 and 50 years of age, respectively. Deceased patients more frequently had renal impairment (50% vs 0%) and QRS prolongation (75% vs 16%) at baseline (all p &lt; 0.05). During follow-up, 40% had a new arrhythmia (atrial: n = 14, ventricular: n = 3), 34% had one or more hospitalizations for heart failure, and 17% had a stroke. A greater proportion of patients with pre-existing or new atrial/ventricular arrhythmia died compared to those without (42% vs 6%, p = 0.02).</p></div><div><h3>Conclusions</h3><p>Patients with SV without Fontan have high mortality and a substantial burden of cardiovascular complications, particularly arrhythmia. QRS prolongation and renal impairment were associated with mortality.</p></div>\",\"PeriodicalId\":73429,\"journal\":{\"name\":\"International journal of cardiology. Congenital heart disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of cardiology. Congenital heart disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666668523000198\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology. Congenital heart disease","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666668523000198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景没有Fontan缓解的单心室(SV)患者并不常见,其长期结果尚不清楚。方法对来自两个三级中心的35例无Fontan的SV成年患者进行回顾性研究。主要结果是死亡率。结果首次随访的中位年龄为31岁(IQR:20-40)。最常见的缺陷是双入口左心室(34%),69%有左心室形态。患者未进行手术(46%),进行全身至肺动脉分流(31%)或双向腔静脉肺动脉分流器(23%)作为最终缓解。未进展为Fontan缓解的最常见原因是肺血管疾病(54%)、患者拒绝(17%)、Fontan消退(14%)和肺动脉发育不全(11%)。基线平均血红蛋白为195±29 g/L,平均氧饱和度为83±6.9%,4名患者为NYHA III-IV级。经过10±8.3年的平均随访,有9例死亡,心力衰竭是主要原因(n=6)。这些成年SV幸存者在40岁和50岁时的年龄调整生存率分别为73%和53%。死亡患者在基线时更频繁地出现肾损伤(50%对0%)和QRS延长(75%对16%)(均p<0.05)。在随访期间,40%出现新的心律失常(心房:n=14,心室:n=3),34%因心力衰竭住院一次或多次,17%中风。与无房性心律失常的患者相比,已有或新发房性/室性心律失常患者的死亡比例更高(42%对6%,p=0.02)。结论无Fontan的SV患者死亡率高,心血管并发症(尤其是心律失常)负担重。QRS波延长和肾功能损害与死亡率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-term outcomes of patients with single ventricle who do not undergo Fontan palliation

Background

Patients with single ventricle (SV) without Fontan palliation are uncommon, and their long-term outcomes remain unclear.

Methods

Retrospective study of 35 adult patients with SV without Fontan from two tertiary centers. Primary outcome was mortality.

Results

Median age at first follow-up was 31 years (IQR: 20–40). Most common defect was double inlet left ventricle (34%), and 69% had left ventricular morphology. Patients were unoperated (46%), had systemic-to-pulmonary artery shunt (31%) or bidirectional cavopulmonary shunt (23%) as final palliation. Most common reasons for not progressing to Fontan palliation were pulmonary vascular disease (54%), patient refusal (17%), Fontan takedown (14%), and hypoplastic pulmonary arteries (11%). Baseline mean hemoglobin was 195 ± 29 g/L, mean O2 saturation 83 ± 6.9%, and 4 patients in NYHA Class III‒IV. After a mean follow-up of 10 ± 8.3 years, there were 9 deaths with heart failure being the leading cause (n = 6). Age-adjusted survival of these adult SV survivors was 73% and 53% at 40 and 50 years of age, respectively. Deceased patients more frequently had renal impairment (50% vs 0%) and QRS prolongation (75% vs 16%) at baseline (all p < 0.05). During follow-up, 40% had a new arrhythmia (atrial: n = 14, ventricular: n = 3), 34% had one or more hospitalizations for heart failure, and 17% had a stroke. A greater proportion of patients with pre-existing or new atrial/ventricular arrhythmia died compared to those without (42% vs 6%, p = 0.02).

Conclusions

Patients with SV without Fontan have high mortality and a substantial burden of cardiovascular complications, particularly arrhythmia. QRS prolongation and renal impairment were associated with mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International journal of cardiology. Congenital heart disease
International journal of cardiology. Congenital heart disease Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
审稿时长
83 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信